CELL & GENE ARTICLES, APP NOTES, CASE STUDIES, & WHITE PAPERS

• Enhancing CRISPR Knock-In And Knock-Out

  Achieve scalable, non-viral CRISPR delivery for T cells. The next-generation electroporation platform provides robust, efficient gene editing in large-scale volumes.

• Why Compliance-Driven CDMOs Win Sponsor Contracts

  Learn how digital maturity and compliance excellence are reshaping CDMO competitiveness, as well as strategies that strengthen performance and accelerate tech transfers.

• Smart Manufacturing: A Strategic Imperative For Pharma's Future

  Pharmaceutical manufacturing is evolving rapidly. Find out how digital technologies like AI, digital twins, and software-defined automation are driving smarter, more agile production.

• Quality Control Of Oligonucleotides Using HPLC Coupled To UV And MS Detection

  Efficient quality control of therapeutic oligonucleotides is crucial. Explore advanced methods combining HPLC-UV and mass spectrometry for precise impurity quantification and mass confirmation.

• Overcoming Rapid Growth Challenges With Process Liquid Preparation

  With a helpful assessment and the right process liquid preparation services, the CDMO featured in this study was able to find a path toward meeting the surge in demand for a client's therapeutic .

• A Journey To Produce MSC-Derived Cell Therapies From Isolation To Large-Scale

  Drive successful MSC therapy development by optimizing isolation methods, surface chemistry, and closed-system expansion technologies to ensure cellular stability and commercial scalability.

• Integrating Cutting-Edge Technologies In Cell Bank Manufacturing

  Discover how our adoption of a counterflow centrifuge enhances GMP-compliant cell banking through closed-system automation, precision harvesting, and scalable workflows.

• Lightning-Link^® Conjugation Kits: Consistent Performance On A Broad Scale

  Learn about labeling technology offering a transformative solution through direct antibody labeling without the need for post-conjugation purification, thereby mitigating antibody loss and ensuring reproducible results.

• Partnering With Health Systems: Essential Tips For CGT Commercialization

  Successful cell and gene therapy commercialization requires early, detailed manufacturer collaboration with health systems to ensure scalable operations and seamless patient access beyond the clinical trial.

• Innovation In Filtration

  Filtration removes contaminants to ensure safety and is essential in various applications, from lab-scale tasks to GMP production. Explore how its simplicity and reliability make it indispensable.